@article{a06ec8f7e7ca438a8b855d96af15a9d9,
title = "Middle east respiratory syndrome vaccine candidates: Cautious optimism",
abstract = "Efforts towards developing a vaccine for Middle East respiratory syndrome coronavirus (MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine approaches have shown efficacy in animal models and begun to enter clinical trials. In this review, we summarize the current progress towards a MERS-CoV vaccine and highlight potential roadblocks identified from previous attempts to generate coronavirus vaccines.",
keywords = "Animal models, Coronavirus spike glycoprotein, Correlates of immunity, Middle East respiratory syndrome coronavirus, Severe acute respiratory syndrome coronavirus, Vaccine platforms",
author = "Craig Schindewolf and Menachery, {Vineet D.}",
note = "Funding Information: Research in this manuscript was supported by grants from the National Institute of Allergy & Infectious Disease and the National Institute of Aging of the NIH under awards U19AI100625 (VDM) and R00AG049092 (VDM). This work was also supported by the McLaughlin Endowment through the Institute of Human Infection and Immunity at the University of Texas Medical Branch. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Publisher Copyright: {\textcopyright} 2019 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2019",
month = jan,
day = "1",
doi = "10.3390/v11010074",
language = "English (US)",
volume = "11",
journal = "Viruses",
issn = "1999-4915",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",
}